Sera Prognostics Long Term Debt 2021-2025 | SERA
Sera Prognostics long term debt from 2021 to 2025. Long term debt can be defined as the sum of all long term debt fields.
|
Sera Prognostics Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $1 |
| 2021 | $0 |
| 2020 | $0 |
|
Sera Prognostics Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-06-30 | |
| 2025-03-31 | |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $1 |
| 2022-06-30 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.102B | $0.000B |
| Sera Prognostics Inc. is a women's health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.807B | 27.32 |
| HCA Healthcare (HCA) | United States | $107.561B | 17.81 |
| CVS Health (CVS) | United States | $99.854B | 11.48 |
| Elevance Health (ELV) | United States | $69.881B | 10.25 |
| Cencora (COR) | United States | $69.843B | 22.53 |
| Natera (NTRA) | United States | $27.241B | 0.00 |
| DiDi Global (DIDIY) | China | $24.615B | 20.11 |
| Labcorp Holdings (LH) | United States | $20.446B | 15.59 |
| Medpace Holdings (MEDP) | United States | $16.681B | 41.41 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.398B | 0.00 |
| ICON (ICLR) | Ireland | $12.921B | 12.82 |
| CochLear (CHEOY) | Australia | $12.049B | 0.00 |
| Viatris (VTRS) | United States | $11.672B | 4.34 |
| Solventum (SOLV) | United States | $11.492B | 11.16 |
| Revvity (RVTY) | United States | $10.149B | 18.69 |
| Charles River Laboratories (CRL) | United States | $8.410B | 16.20 |
| HealthEquity (HQY) | United States | $7.990B | 31.98 |
| Avantor (AVTR) | United States | $7.718B | 11.79 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.944B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.618B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.879B | 35.05 |
| Bausch + Lomb (BLCO) | Canada | $5.501B | 36.12 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.984B | 70.41 |
| Alignment Healthcare (ALHC) | United States | $3.300B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.771B | 34.85 |
| Concentras Parent (CON) | United States | $2.398B | 14.97 |
| Premier (PINC) | United States | $2.323B | 22.51 |
| Ardent Health (ARDT) | United States | $2.069B | 7.99 |
| PACS (PACS) | United States | $1.902B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.880B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.874B | 11.19 |
| Organon (OGN) | United States | $1.744B | 1.90 |
| Progyny (PGNY) | United States | $1.549B | 30.52 |
| Teladoc Health (TDOC) | United States | $1.352B | 0.00 |
| Omada Health (OMDA) | $1.259B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.098B | 17.56 |
| Embecta (EMBC) | United States | $0.787B | 4.61 |
| CareDx (CDNA) | United States | $0.772B | 12.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 9.75 |
| Nutex Health (NUTX) | United States | $0.676B | 10.24 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Pomdoctor - (POM) | China | $0.616B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.587B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| So-Young (SY) | China | $0.434B | 0.00 |
| CryoPort (CYRX) | United States | $0.417B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.409B | 6.14 |
| Enhabit (EHAB) | United States | $0.390B | 17.52 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Oncology Institute (TOI) | United States | $0.356B | 0.00 |
| Charming Medical (MCTA) | $0.350B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.320B | 7.00 |
| KindlyMD (NAKA) | United States | $0.320B | 0.00 |
| Agilon Health (AGL) | United States | $0.289B | 0.00 |
| LifeMD (LFMD) | United States | $0.249B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.228B | 0.00 |
| Beauty Health (SKIN) | United States | $0.164B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.146B | 24.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.028B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.78 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |